Complement Interactions with Blood Cells, Endothelial Cells and Microvesicles in Thrombotic and Inflammatory Conditions (Q33425421)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Complement Interactions with Blood Cells, Endothelial Cells and Microvesicles in Thrombotic and Inflammatory Conditions	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Complement Interactions with Blood Cells, Endothelial Cells and Microvesicles in Thrombotic and Inflammatory Conditions (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

0 references

1

object named as

Diana Karpman

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Anne-lie Ståhl

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Ida Arvidsson

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Karl Johansson

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sebastian Loos

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Ramesh Tati

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Zivile Békássy

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Ann-Charlotte Kristoffersson

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Maria Mossberg

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Robin Kahn

10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

1 January 2015

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Advances in Experimental Medicine and Biology

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

865

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

19-42

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Complement. First of two parts

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Receptors, rafts, and microvesicles in thrombosis and inflammation

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Complement and complement regulatory proteins as potential molecular targets for vascular diseases

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

The endothelium is an extrahepatic site of synthesis of the seventh component of the complement system

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Identification of C1q as the heat-labile serum cofactor required for immune complexes to stimulate endothelial expression of the adhesion molecules E-selectin and intercellular and vascular cell adhesion molecules 1.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Cross-talk between the complement system and endothelial cells in physiologic conditions and in vascular diseases

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Complement-mediated injury and protection of endothelium: lessons from atypical haemolytic uraemic syndrome

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

The contact/kinin and complement systems in vasculitis

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Cross-talk between the complement and the kinin system in vascular permeability

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Platelet-activating factor and kinin-dependent vascular leakage as a novel functional activity of the soluble terminal complement complex

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Cytolytically inactive terminal complement complex causes transendothelial migration of polymorphonuclear leukocytes in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Complement-mediated regulation of tissue factor activity in endothelium

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Cellular mechanisms underlying the formation of circulating microparticles

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Ectocytosis caused by sublytic autologous complement attack on human neutrophils. The sorting of endogenous plasma-membrane proteins and lipids into shed vesicles

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Endothelial activation and circulating markers of endothelial activation in kidney disease

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Microvesicles and viral infection

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Microparticles: protagonists of a novel communication network for intercellular information exchange

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Leukocyte-derived microparticles in vascular homeostasis.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Red blood cell microparticles: clinical relevance

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Endothelial microparticles in diseases

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Highlights of a new type of intercellular communication: microvesicle-based information transfer.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Modulation of monocyte-endothelial cell interactions by platelet microparticles

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

The many faces of endothelial microparticles.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

p38 mitogen-activated protein kinase targets the production of proinflammatory endothelial microparticles.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Regulation of transbilayer plasma membrane phospholipid asymmetry

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Microparticles in hemostasis and thrombosis.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Red blood cell-derived microparticles isolated from blood units initiate and propagate thrombin generation

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Shiga toxin and lipopolysaccharide induce platelet-leukocyte aggregates and tissue factor release, a thrombotic mechanism in hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Shiga toxin-induced complement-mediated hemolysis and release of complement-coated red blood cell-derived microvesicles in hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Role of microparticles in atherothrombosis

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

A novel mechanism of bacterial toxin transfer within host blood cell-derived microvesicles

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Complement activation associated with ADAMTS13 deficiency in human and murine thrombotic microangiopathy

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Microthrombocytosis and Platelet Fragmentation Associated with Idiopathic/Autoimmune Thrombocytopenic Purpura

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Endothelial and platelet microparticles in vasculitis of the young.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Flow cytometry detection of Shiga toxins in the blood from children with hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Clinical relevance of shiga toxin concentrations in the blood of patients with hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

The detection of Shiga toxins in the kidney of a patient with hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Localization of Shiga toxins of enterohaemorrhagic Escherichia coli in kidneys of paediatric and geriatric patients with fatal haemolytic uraemic syndrome

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Identification of TLR4 as the receptor that recognizes Shiga toxins in human neutrophils

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Specific Interaction of Escherichia coli 0157:H7-Derived Shiga-like Toxin II with Human Renal Endothelial Cells

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Cytotoxic effect of Shiga toxin-1 on human proximal tubule cells

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Shiga toxin 2 and lipopolysaccharide cause monocytic THP-1 cells to release factors which activate platelet function

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Shiga toxin 2 and lipopolysaccharide induce human microvascular endothelial cells to release chemokines and factors that stimulate platelet function

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Platelet activation by Shiga toxin and circulatory factors as a pathogenetic mechanism in the hemolytic uremic syndrome.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Platelet activation in hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Experimental studies on the hemolytic-uremic syndrome

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Hemolytic uremic syndrome in children: platelet aggregation and membrane glycoproteins

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

von Willebrand factor and von Willebrand factor-cleaving metalloprotease activity in Escherichia coli O157:H7-associated hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

The fibrinolytic system in the hemolytic uremic syndrome: in vivo and in vitro studies

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Verotoxin-1-induced up-regulation of adhesive molecules renders microvascular endothelial cells thrombogenic at high shear stress

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Platelet activation leads to activation and propagation of the complement system

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Studies on the binding of complement factor C4 in human platelets. Complement activation by means of cold agglutinins

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Activation of human platelets through gp140, the C3d/EBV receptor (CR2)

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Human platelet-initiated formation and uptake of the C5-9 complex of human complement

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Human complement in thrombin-mediated platelet function: uptake of the C5b-9 complex

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Human platelet activation by C3a and C3a des-arg

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Mechanism of complement-mediated activation of human blood platelets in vitro: comparison of normal and paroxysmal nocturnal hemoglobinuria platelets

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Identification of a third component of complement-binding glycoprotein of human platelets

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Isolation and characterization of the complement-inhibiting protein CD59 antigen from platelet membranes

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Factor H binds to washed human platelets.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Platelet-associated complement factor H in healthy persons and patients with atypical HUS.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Association of alternative complement pathway components with human blood platelets: secretion and localization of factor D and beta 1H Globulin

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Role of plasminogen-activator inhibitor type 1 in the pathogenesis and outcome of the hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Hypocomplementemia and leukocytosis in diarrhea-associated hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Microparticle generation and leucocyte death in Shiga toxin-mediated HUS.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Complement and the atypical hemolytic uremic syndrome in children.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Eculizumab in an anephric patient with atypical haemolytic uraemic syndrome and advanced vascular lesions

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Thrombomodulin mutations in atypical hemolytic-uremic syndrome

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

A novel mutation in the complement regulator clusterin in recurrent hemolytic uremic syndrome.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Complement factor H related proteins in immune diseases

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

A novel C3 mutation causing increased formation of the C3 convertase in familial atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Thrombotic microangiopathy mimicking membranoproliferative glomerulonephritis.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Complement factor B mutations in atypical hemolytic uremic syndrome-disease-relevant or benign?

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

The development of atypical hemolytic uremic syndrome depends on complement C5

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Molecular basis of ADAMTS13 dysfunction in thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Complement activation in thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Complement and cytokine response in acute Thrombotic Thrombocytopenic Purpura

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Thrombotic Thrombocytopenic Purpura with C′3Vascular Deposits: Report of a Case

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Eculizumab in the treatment of refractory idiopathic thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Complement activation: the missing link between ADAMTS-13 deficiency and microvascular thrombosis of thrombotic microangiopathies

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Assembly and activation of alternative complement components on endothelial cell-anchored ultra-large von Willebrand factor links complement and hemostasis-thrombosis

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

The interaction between factor H and Von Willebrand factor

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

The interaction between factor H and VWF increases factor H cofactor activity and regulates VWF prothrombotic status

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Human complement factor H is a reductase for large soluble von Willebrand factor multimers--brief report

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Endothelial microparticles released in thrombotic thrombocytopenic purpura express von Willebrand factor and markers of endothelial activation

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Endothelial microparticles induce formation of platelet aggregates via a von Willebrand factor/ristocetin dependent pathway, rendering them resistant to dissociation

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Review article: The role of CD4(+) T cells in ANCA-associated systemic vasculitis

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Anti-PR3 immune responses induce segmental and necrotizing glomerulonephritis

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Clinical variability and characteristic autoantibody profile in primary C1q complement deficiency

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Rheumatological manifestations, organ damage and autoimmunity in hereditary C2 deficiency

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Endothelial microparticles and the diagnosis of the vasculitides

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Diagnostic role of endothelial microparticles in vasculitis.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Increase of circulating neutrophil and platelet microparticles during acute vasculitis and hemodialysis

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Anti-neutrophil cytoplasmic antibodies stimulate release of neutrophil microparticles

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Neutrophil-derived microparticles induce myeloperoxidase-mediated damage of vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Management of Shiga toxin-associated Escherichia coli-induced haemolytic uraemic syndrome: randomized clinical trials are needed

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Eculizumab in severe Shiga-toxin-associated HUS

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

An outbreak of Shiga toxin-producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Use of eculizumab in the treatment of a case of refractory, ADAMTS13-deficient thrombotic thrombocytopenic purpura: additional data and clinical follow-up

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Dramatic effects of eculizumab in a child with diffuse proliferative lupus nephritis resistant to conventional therapy

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Thrombotic microangiopathy in systemic lupus erythematosus: efficacy of eculizumab

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Progress and Trends in Complement Therapeutics

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-18603-0_2

31 March 2020

Identifiers

10.1007/978-3-319-18603-0_2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33425421&oldid=1960550554"